메뉴 건너뛰기




Volumn 5, Issue 7, 2015, Pages

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

(21)  Padron, E a   Garcia Manero, G b   Patnaik, M M c   Itzykson, R d   Lasho, T c   Nazha, A e   Rampal, R K f   Sanchez, M E f   Jabbour, E b   Al Ali, N H a   Thompson, Z a   Colla, S b   Fenaux, P g   Kantarjian, H M b   Killick, S h   Sekeres, M A e   List, A F a   Onida, F i   Komrokji, R S j   Tefferi, A c   more..


Author keywords

[No Author keywords available]

Indexed keywords

ASXL1 PROTEIN; CBL PROTEIN; HEMOGLOBIN; JANUS KINASE 2; PROTEIN; SRSF2 PROTEIN; TET2 PROTEIN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

EID: 84989332686     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2015.53     Document Type: Article
Times cited : (111)

References (32)
  • 1
    • 84897407751 scopus 로고    scopus 로고
    • The clinical management of chronic myelomonocytic leukemia
    • Padron E, Komrokji R, List AF. The clinical management of chronic myelomonocytic leukemia. Clin Adv Hematol Oncol 2014; 12: 172-178.
    • (2014) Clin Adv Hematol Oncol , vol.12 , pp. 172-178
    • Padron, E.1    Komrokji, R.2    List, A.F.3
  • 2
    • 84883619210 scopus 로고    scopus 로고
    • Management recommendations for chronic myelomonocytic leukemia: Consensus statements from the SIE, SIES, GITMO groups
    • Onida F, Barosi G, Leone G, Malcovati L, Morra E, Santini V et al. Management recommendations for chronic myelomonocytic leukemia: Consensus statements from the SIE, SIES, GITMO groups. Haematologica 2013; 98: 1344-1352.
    • (2013) Haematologica , vol.98 , pp. 1344-1352
    • Onida, F.1    Barosi, G.2    Leone, G.3    Malcovati, L.4    Morra, E.5    Santini, V.6
  • 3
    • 0017162163 scopus 로고
    • Proposals for the classification of the acute leukaemias French-American-British (FAB) Co-operative Group
    • Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) Co-operative Group. Br J Haematol 1976; 33: 451-458.
    • (1976) Br J Haematol , vol.33 , pp. 451-458
    • Bennett, J.M.1    Catovsky, D.2    Daniel, M.-T.3    Flandrin, G.4    Galton, D.A.G.5    Gralnick, H.R.6
  • 4
    • 70349256226 scopus 로고    scopus 로고
    • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes
    • Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009; 114: 937-951.
    • (2009) Blood , vol.114 , pp. 937-951
    • Vardiman, J.W.1    Thiele, J.2    Arber, D.A.3    Brunning, R.D.4    Borowitz, M.J.5    Porwit, A.6
  • 5
    • 84888219405 scopus 로고    scopus 로고
    • Clinical and biological implications of driver mutations in myelodysplastic syndromes
    • Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122: 3616-3627.
    • (2013) Blood , vol.122 , pp. 3616-3627
    • Papaemmanuil, E.1    Gerstung, M.2    Malcovati, L.3    Tauro, S.4    Gundem, G.5    Van Loo, P.6
  • 7
    • 84905907421 scopus 로고    scopus 로고
    • ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia
    • Padron E, Yoder S, Kunigal S, Mesa T, Teer JK, Al Ali N et al. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Blood 2014; 123: 3675-3677.
    • (2014) Blood , vol.123 , pp. 3675-3677
    • Padron, E.1    Yoder, S.2    Kunigal, S.3    Mesa, T.4    Teer, J.K.5    Al Ali, N.6
  • 8
    • 84882396666 scopus 로고    scopus 로고
    • GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
    • Padron E, Painter JS, Kunigal S, Mailloux AW, McGraw K, McDaniel JM et al. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood 2013; 121: 5068-5077.
    • (2013) Blood , vol.121 , pp. 5068-5077
    • Padron, E.1    Painter, J.S.2    Kunigal, S.3    Mailloux, A.W.4    McGraw, K.5    McDaniel, J.M.6
  • 9
    • 84880263477 scopus 로고    scopus 로고
    • Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
    • Patnaik MM, Padron E, Laborde RR, Lasho TL, Finke CM, Hanson CA et al. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia 2013; 27: 1504-1510.
    • (2013) Leukemia , vol.27 , pp. 1504-1510
    • Patnaik, M.M.1    Padron, E.2    Laborde, R.R.3    Lasho, T.L.4    Finke, C.M.5    Hanson, C.A.6
  • 10
    • 84866621729 scopus 로고    scopus 로고
    • Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes
    • Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 2012; 120: 2454-2465.
    • (2012) Blood , vol.120 , pp. 2454-2465
    • Greenberg, P.L.1    Tuechler, H.2    Schanz, J.3    Sanz, G.4    Garcia-Manero, G.5    Sole, F.6
  • 11
    • 0030897009 scopus 로고    scopus 로고
    • International scoring system for evaluating prognosis in myelodysplastic syndromes
    • Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
    • (1997) Blood , vol.89 , pp. 2079-2088
    • Greenberg, P.1    Cox, C.2    LeBeau, M.M.3    Fenaux, P.4    Morel, P.5    Sanz, G.6
  • 12
    • 84877069358 scopus 로고    scopus 로고
    • Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
    • Such E, Germing U, Malcovati L, Cervera J, Kuendgen A, Della Porta MG et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood 2013; 121: 3005-3015.
    • (2013) Blood , vol.121 , pp. 3005-3015
    • Such, E.1    Germing, U.2    Malcovati, L.3    Cervera, J.4    Kuendgen, A.5    Della Porta, M.G.6
  • 13
    • 0026504855 scopus 로고
    • Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system
    • Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6: 52-59.
    • (1992) Leukemia , vol.6 , pp. 52-59
    • Aul, C.1    Gattermann, N.2    Heyll, A.3    Germing, U.4    Derigs, G.5    Schneider, W.6
  • 15
    • 84922332658 scopus 로고    scopus 로고
    • ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: A two-center study of 466 patients
    • Patnaik MM, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA et al. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: A two-center study of 466 patients. Leukemia 2014; 28: 2206-2212.
    • (2014) Leukemia , vol.28 , pp. 2206-2212
    • Patnaik, M.M.1    Itzykson, R.2    Lasho, T.L.3    Kosmider, O.4    Finke, C.M.5    Hanson, C.A.6
  • 16
    • 84922393115 scopus 로고    scopus 로고
    • Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: A Mayo Clinic-French Consortium Study
    • Wassie EA, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA et al. Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: A Mayo Clinic-French Consortium Study. Am J Hematol 2014; 89: 1111-1115.
    • (2014) Am J Hematol , vol.89 , pp. 1111-1115
    • Wassie, E.A.1    Itzykson, R.2    Lasho, T.L.3    Kosmider, O.4    Finke, C.M.5    Hanson, C.A.6
  • 17
    • 0036464647 scopus 로고    scopus 로고
    • Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients
    • Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients. Blood 2002; 99: 840-849.
    • (2002) Blood , vol.99 , pp. 840-849
    • Onida, F.1    Kantarjian, H.M.2    Smith, T.L.3    Ball, G.4    Keating, M.J.5    Estey, E.H.6
  • 18
    • 53149113768 scopus 로고    scopus 로고
    • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
    • Kantarjian H, O'Brien S, Ravandi F, Cortes J, Shan J, Bennett JM et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008; 113: 1351-1361.
    • (2008) Cancer , vol.113 , pp. 1351-1361
    • Kantarjian, H.1    O'Brien, S.2    Ravandi, F.3    Cortes, J.4    Shan, J.5    Bennett, J.M.6
  • 19
    • 47249150213 scopus 로고    scopus 로고
    • Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
    • Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008; 112: 45-52.
    • (2008) Blood , vol.112 , pp. 45-52
    • Rollison, D.E.1    Howlader, N.2    Smith, M.T.3    Strom, S.S.4    Merritt, W.D.5    Ries, L.A.6
  • 20
    • 84921433666 scopus 로고    scopus 로고
    • The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
    • Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P et al. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands. Leukemia research 2014; 39: 177-182.
    • (2014) Leukemia research , vol.39 , pp. 177-182
    • Dinmohamed, A.G.1    Van Norden, Y.2    Visser, O.3    Posthuma, E.F.4    Huijgens, P.C.5    Sonneveld, P.6
  • 21
    • 84888259429 scopus 로고    scopus 로고
    • Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
    • quiz 2920
    • Takahashi K, Pemmaraju N, Strati P, Nogueras-Gonzalez G, Ning J, Bueso-Ramos C et al. Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia. Blood 2013; 122: 2807-2811; quiz 2920.
    • (2013) Blood , vol.122 , pp. 2807-2811
    • Takahashi, K.1    Pemmaraju, N.2    Strati, P.3    Nogueras-Gonzalez, G.4    Ning, J.5    Bueso-Ramos, C.6
  • 23
    • 0026770594 scopus 로고
    • Relative risk trees for censored survival data
    • LeBlanc M, Crowley J. Relative risk trees for censored survival data. Biometrics 1992; 48: 411-425.
    • (1992) Biometrics , vol.48 , pp. 411-425
    • LeBlanc, M.1    Crowley, J.2
  • 24
    • 79952837540 scopus 로고    scopus 로고
    • Identifying important risk factors for survival in patient with systolic heart failure using random survival forests
    • Hsich E, Gorodeski EZ, Blackstone EH, Ishwaran H, Lauer MS. Identifying important risk factors for survival in patient with systolic heart failure using random survival forests. Circ Cardiovasc Qual Outcomes 2011; 4: 39-45.
    • (2011) Circ Cardiovasc Qual Outcomes , vol.4 , pp. 39-45
    • Hsich, E.1    Gorodeski, E.Z.2    Blackstone, E.H.3    Ishwaran, H.4    Lauer, M.S.5
  • 25
    • 84867253750 scopus 로고    scopus 로고
    • SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
    • Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V et al. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012; 120: 3080-3088.
    • (2012) Blood , vol.120 , pp. 3080-3088
    • Meggendorfer, M.1    Roller, A.2    Haferlach, T.3    Eder, C.4    Dicker, F.5    Grossmann, V.6
  • 27
    • 84859597590 scopus 로고    scopus 로고
    • Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
    • Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012; 119: 3203-3210.
    • (2012) Blood , vol.119 , pp. 3203-3210
    • Makishima, H.1    Visconte, V.2    Sakaguchi, H.3    Jankowska, A.M.4    Abu Kar, S.5    Jerez, A.6
  • 28
    • 77956237515 scopus 로고    scopus 로고
    • Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1
    • Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010; 28: 3858-3865.
    • (2010) J Clin Oncol , vol.28 , pp. 3858-3865
    • Kohlmann, A.1    Grossmann, V.2    Klein, H.U.3    Schindela, S.4    Weiss, T.5    Kazak, B.6
  • 29
    • 84915750567 scopus 로고    scopus 로고
    • Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias
    • Schuler E, Schroeder M, Neukirchen J, Strupp C, Xicoy B, Kundgen A et al. Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias. Leuk Res 2014; 38: 1413-1419.
    • (2014) Leuk Res , vol.38 , pp. 1413-1419
    • Schuler, E.1    Schroeder, M.2    Neukirchen, J.3    Strupp, C.4    Xicoy, B.5    Kundgen, A.6
  • 30
  • 31
    • 84904042955 scopus 로고    scopus 로고
    • CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: Clinical, cytogenetic and molecular comparisons
    • Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: Clinical, cytogenetic and molecular comparisons. Leukemia 2014; 28: 1472-1477.
    • (2014) Leukemia , vol.28 , pp. 1472-1477
    • Tefferi, A.1    Lasho, T.L.2    Finke, C.M.3    Knudson, R.A.4    Ketterling, R.5    Hanson, C.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.